Published in Drug Week, June 11th, 2004
"The PCPT is a randomized double blind chemoprevention trial of 18,882 men," scientists in the United States report.
It is designed to test the difference in the histologically proven prostate cancer prevalence between a group of participants given finasteride and another given placebo for 7 years," wrote P.J. Goodman and colleagues, Southwest Oncology Group, San Antonio.
"We present an overview of the study design, details of the administrative structure of the study, and a description of the successful...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.